Education
About Us
Working with TipRanks
Follow Us
Collplant Holdings (CLGN)
NASDAQ:CLGN
CLGN Stock Chart & Stats
$2.23
-$0.10(-2.34%)
At close: 4:00 PM EST
$2.23
-$0.10(-2.34%)
Day’s Range― - ―
52-Week Range$1.31 - $4.98
Previous CloseN/A
Volume800.00
Average Volume (3M)29.18K
Market Cap
$28.36M
Enterprise ValueN/A
Total Cash (Recent Filing)$11.71M
Total Debt (Recent Filing)$3.03M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Apr 02, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding12,716,014
10 Day Avg. Volume15,198
30 Day Avg. Volume29,183
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)3.06
Price to Sales (P/S)80.07
P/FCF Ratio-2.83
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
PartnershipsCollPlant continues to progress the clinical development of its dermal and soft-tissue filler program in collaboration with AbbVie.
Product DevelopmentEncouraging initial breast implant data shows signs of implant integration and rapid growth of native tissue, supporting potential future commercialization.
Bears Say
Financial PerformanceThe company reported total revenues of $0.25M, compared to the consensus estimate of $0.69M.
Collplant Holdings News
CLGN FAQ
What was Collplant Holdings’s price range in the past 12 months?
Collplant Holdings lowest stock price was $1.31 and its highest was $4.98 in the past 12 months.
What is Collplant Holdings’s market cap?
Collplant Holdings’s market cap is $28.36M.
When is Collplant Holdings’s upcoming earnings report date?
Collplant Holdings’s upcoming earnings report date is Apr 02, 2026 which is in 124 days.
How were Collplant Holdings’s earnings last quarter?
Collplant Holdings released its earnings results on Nov 26, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of $0.155 by -$0.425.
Is Collplant Holdings overvalued?
According to Wall Street analysts Collplant Holdings’s price is currently Overvalued.
Does Collplant Holdings pay dividends?
Collplant Holdings does not currently pay dividends.
What is Collplant Holdings’s EPS estimate?
Collplant Holdings’s EPS estimate is -0.07.
How many shares outstanding does Collplant Holdings have?
Collplant Holdings has 12,716,014 shares outstanding.
What happened to Collplant Holdings’s price movement after its last earnings report?
Collplant Holdings reported an EPS of -$0.27 in its last earnings report, missing expectations of $0.155. Following the earnings report the stock price went down -0.446%.
Which hedge fund is a major shareholder of Collplant Holdings?
Currently, no hedge funds are holding shares in CLGN
Company Description
Collplant Holdings
CollPlant Holdings (CLGN) is a biotechnology company focused on developing and commercializing innovative regenerative medicine products based on its proprietary recombinant human collagen technology. The company operates primarily in the biotechnology and medical sectors, with a core emphasis on wound healing, tissue regeneration, and aesthetic applications. CollPlant's flagship products include its collagen-based solutions for skin and soft tissue repair, as well as its advanced aesthetic treatments that leverage collagen's biocompatibility and functionality.
Technical Analysis
Daré Bioscience
―
Passage Bio
―
PolyPid
―
SAB Biotherapeutics
―
Neurosense Therapeutics Ltd.
―
Ownership Overview
―
Insiders
0.05% Mutual Funds
12.81% Other Institutional Investors
87.15% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---